These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 1463144)

  • 21. [Epidemiologic panorama of viral hepatitis in Mexico].
    Murguía-Martínez P; Kuri-Morales P
    Gac Med Mex; 1997; 133(5):487-92. PubMed ID: 9504079
    [No Abstract]   [Full Text] [Related]  

  • 22. [An epidemiology study on acute sporadic viral hepatitis in Taiyuan].
    Wang JS
    Zhonghua Yu Fang Yi Xue Za Zhi; 1986 Mar; 20(2):92-4. PubMed ID: 3095066
    [No Abstract]   [Full Text] [Related]  

  • 23. Patterns of viral hepatitis in Hong Kong.
    Leung NW
    Br J Hosp Med; 1997 Aug 20-Sep 2; 58(4):166-9. PubMed ID: 9373408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
    González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
    Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute viral hepatitis in Singapore.
    Chan SH; Chew TS; Oon CJ; Ho KT; Seah CS
    Singapore Med J; 1982 Apr; 23(2):90-2. PubMed ID: 6813971
    [No Abstract]   [Full Text] [Related]  

  • 26. [Viral markers of acute hepatitis: a study in 291 children and adults in Chile].
    Velasco M; Puelma E; Katz R; Zacarías J
    Rev Med Chil; 1982 Jun; 110(6):542-6. PubMed ID: 6819623
    [No Abstract]   [Full Text] [Related]  

  • 27. [The epidemiology of viral hepatitis].
    Anusz Z
    Pieleg Polozna; 1983; (1):3-7. PubMed ID: 6444084
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prophylaxis of viral hepatitis].
    Juanes JR; Arrazola MP; Aragón AJ; Dávila Alvarez FM
    Enferm Infecc Microbiol Clin; 1995 Apr; 13 Suppl 1():62-70. PubMed ID: 7772625
    [No Abstract]   [Full Text] [Related]  

  • 30. The frequency of non-A, non-B hepatitis in acute and chronic liver disease.
    Ross IN; Madhavan HN; Tan Sok Hoong ; Abdul Rahim KB
    Med J Malaysia; 1985 Dec; 40(4):301-6. PubMed ID: 3025569
    [No Abstract]   [Full Text] [Related]  

  • 31. [A population-based study on types of viral hepatitis].
    Che XG
    Zhonghua Yu Fang Yi Xue Za Zhi; 1991 Mar; 25(2):82-4. PubMed ID: 1907238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Viral hepatitis--trends].
    Manciuc C; Dorobăţ C; Filip-Ciubotaru FM
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):327-31. PubMed ID: 20700962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidemiological research on human viral hepatitis in the province of Pavia].
    Meloni C; Belloni E; Giorgi A; Marchetti R; Pelissero G; Zecca E; Rondanelli EG; Carosi G; Corridori S; De Franchis R
    Nuovi Ann Ig Microbiol; 1982; 33(4-6):697-724. PubMed ID: 7187498
    [No Abstract]   [Full Text] [Related]  

  • 34. [Viral hepatitis--1989].
    Szata W
    Przegl Epidemiol; 1991; 45(1-2):77-89. PubMed ID: 1796168
    [No Abstract]   [Full Text] [Related]  

  • 35. [Etiology and epidemiology of 547 episodes of acute viral hepatitis diagnosed in adults in a general hospital (1983-1994)].
    Rodriguez M; Martinez A; Sala P; Pérez R; Linares A; Sánchez-Lombraña JL; Rodrigo L
    Gastroenterol Hepatol; 1996; 19(6):285-91. PubMed ID: 8754414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A two dose combined hepatitis A and B vaccine in Chinese youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A
    J Med Virol; 1999 Sep; 59(1):1-4. PubMed ID: 10440800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recommendations for protection against viral hepatitis. Recommendation of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1985 Sep; 103(3):391-402. PubMed ID: 3161440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of sporadic acute non-A, non-B hepatitis in Japan: a comparison with hepatitis A and B.
    Nagata A; Kiyosawa K; Koike Y; Miura M; Gibo Y; Sodeyama T; Wada S; Akahane Y; Furuta S
    Am J Gastroenterol; 1985 Apr; 80(4):298-302. PubMed ID: 3920901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epidemiology of viral hepatitis in Algeria].
    Khalfa S; Ardjoun H
    Med Trop (Mars); 1984; 44(3):247-52. PubMed ID: 6438432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevalence of anti-HAV antibodies in Warsaw population].
    Janaszek-Seydlitz W; Bucholc B; Wiatrzyk A
    Przegl Epidemiol; 2007; 61(4):675-82. PubMed ID: 18572499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.